KIR3DL2 expression in CTCL. (A) KIR3DL2 expression in CTCL subtypes compared with healthy donors and EID patients (MF, including 2 granulomatous slack skin and 6 folliculotropic MF cases). αβ subcut, subcutaneous panniculitis-like αβ T-cell lymphoma; γδTCL, cutaneous γδ T-cell lymphoma; CD8-AETCL, CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma; HTLV1, HTLV1 adult T-cell lymphoma; LyP, lymphomatoid papulosis; TNK, T/NK nasal-type lymphoma; T nos, cutaneous peripheral T-cell lymphoma not otherwise specified. (B) KIR3DL2 expression according to International Society for Cutaneous Lymphomas European Organisation for Research and Treatment of Cancer disease stage in MF, tMF, and SS patients. **P < .01; ***P < .001.